Table 1.
References | Scientific name | Parts used | Animal | Dose | Route | Methods used | Action mechanism |
---|---|---|---|---|---|---|---|
Trovato et al., 2001 [11] | H. empetrifolium | APME | Wistar rats | 100 mg/kg | i.p. | CIPE | Inhibition of PG |
Ozturk et al., 2002 [12] | H. triquetrifolium | DAPE | Wistar rats | 25–60 mg/kg | i.p. | CIPE | Without mechanism |
Rabanal et al., 2005 [13] | H. canariense; H. glandulosum | BME | Swiss mice | 0.25–1 mg/ear | t.a. | TPAIEE | Inhibition of AA metabolism |
Abdel-Salam 2005 [14] | H. perforatum | Commercial extract | Sprague-Dawley rats | 50–300 mg/kg | s.c. | CIPE | Inhibition of the liberation of HIS, 5-HT, KN |
Sánchez-Mateo et al., 2006 [15] | H. reflexum | BME | Swiss mice | 0.25–1 mg/ear | t.a. | TPAIEE | Inhibition of PLA2, COX, and LOX |
Nguemfo et al., 2007 [16] | A. monticola | SBMCME | Wistar rats | 75–300 mg/kg | p.o. | CIPE; HSIPE; AAIPE; DIPE | Inhibition of AA metabolism |
Šavikin et al., 2007 [17] | H. perforatum; H. barbatum; H. hirsutum; H. richeri; H. androsaemum. | DAPE | Wistar rats | 25–200 mg/kg | p.o. | CIPE | Inhibition of NF-κB. |
Frutuoso et al., 2007 [18] | R. longifolia | LAE | Swiss mice; Wistar rats | 10–100 mg/kg | p.o. | PILPS | Inhibition of neutrophil |
Ymele et al., 2013 [19] | A. gabonensis | SBAE | Wistar rats | 100–400 mg/kg | p.o. | CIPE; HSIPE | Reduced liberation and action of His and 5-HT; inhibition AA metabolism |
Šavikin et al., 2007 [17] | H. perforatum; H. barbatum; H. hirsutum; H. richeri; H. androsaemum. | DAPE | Wistar rats | 25–200 mg/kg | p.o. | CIPE | Inhibition of NF-κB. |
Panthong et al., 2007 [20] | G. hanburyi | BEAE | Sprague-Dawley rats | 10–40 mg/kg | p.o. | EPPIEE; CIPE; AAIPE; GGICP | Inhibition of the liberation of His, PG, KN |
Castardo et al., 2008 [21] | G. gardneriana | LHE | Swiss mice | 30–300 mg/kg | i.p. | CIPE; HSIPE; TPAIPE; BKIPE; AAIPE MPOAA; SPIPE | Inhibition of the activity of neuropeptides and PKC |
Galati et al., 2008 [22] | H. rumeliacum | APME | Wistar rats | 50; 70 mg/kg | i.p. | CIPE | Without mechanism |
Martins et al., 2008 [23] | G. brasiliensis | FPO | Wistar rats | 100 mg/kg | p.o. | CIPE | Without mechanism |
dos Reis et al., 2009 [24] | G. cambogia | FPE | Wistar rats | 0.5; 1.0 g/kg | p.o. | CITNBS; MPOAA; EMPGE2 | Inhibition COX-2 expression and production of PGE2 |
Zdunić et al., 2009 [25] | H. perforatum | FTOE | Wistar rats | 1.25 mL/Kg | p.o. | CIPE | Without mechanism |
Paterniti et al., 2010 [26] | H. Perforatum | ME | Sprague-Dawley rats | 2 mg/kg | PIL; MPOAA; MVP; CE | Reduces the NF-κB translocation; inhibition the IκB-α degradation; attenuation of the expression of iNOS | |
Sntar et al., 2010 [27] | H. perforatum | APOOE; APEE | Sprague-Dawley rats; Swiss mice | 50–400 mg/kg | p.o. | AcAICP | Without mechanism |
Otuki et al., 2011 [28] | G. gardneriana | LHE; BHE; SHE | Swiss Webster mice | 0.01–1 mg/ear | t.a. | COIEE; MPOAA | Inflammatory signal transduction pathway not specified |
Ozturk et al., 2011 [12] | G. brasiliensis | LEE | Wistar rats | 30–300 mg/kg | p.o. | CIPE; PILPS; GGICP | Inhibition of the liberation of His, 5-HT, and BK |
Santos et al., 2011 [29] | C. nemorosa | LHxE | Swiss mice | 50–200 mg/kg | i.p. | CIP; MTP; MTNF-α; GGICP | Inhibition of the neutrophil migration |
Abbreviations of parts used: APME: aerial parts methanol extract; APEE: aerial parts ethanolic extract; APOOE: aerial parts olive oil extract; BEAE: bark ethyl acetate extract; BHE: bark hydroalcoholic extract; BME: blossom methanol extract; DAPE: dried aerial parts extract; FPE: fruit peel extract; FPO: fruit pee oil; FTOE: flowering tops oil extracts; LAE: leaves aqueous extract; LHE: leaves hydroalcoholic extract; LEE: leaves ethanolic extract; LHxE: leaves hexanic extract; ME: methanolic extract; SBAE: stem bark aqueous extract; SBMCME: stem barks methylene chloride/methanol extract; SHE: seeds hydroalcoholic extract.
Abbreviations of administration routes: i.p.: intraperitoneal; p.o.: oral administration; t.a.: topical administration.
Abbreviations of methods used: AAIPE: arachidonic acid-induced paw edema; AcAICP: acetic acid-induced increase in capillary permeability; BKIPE: bradykinin induced paw edema; CE: cytokines expression; CIP: carrageenan-induced pleurisy; CIPE: carrageenan-induced paw edema; CITNBS: colitis induced by 2,4,6-trinitrobenzenesulfonic acid; DIPE; dextran-induced paw edema; COIEE: croton oil-induced ear edema; EMPGE2: evaluation of mucosal PGE2; EPPIEE: ethyl phenylpropiolate induced ear edema; GGICP: granulomatous growth induced by cotton pellet; HSIPE: histamine and serotonin induced paw edema; MPOAA: myeloperoxidase activity assay; MTNF-α: measurement of tumor necrosis factor alpha; MTP: measurement of total protein; PEILPS: peritonitis induced by lipopolysaccharide; PIL: peritonitis induced by ligature; PILPS: pleurisy induced by LPS; SPIPE: substance P induced paw edema; TPAIPE: 12-O-tetradecanoylphorbol 13-acetate induced paw edema.
Abbreviations of action mechanism: AA: arachidonic acid; BK: bradykinin; COX: cyclooxygenase; His: histamine; iNOS: inducible nitric oxide synthase; KN: kinins; LOX: lipoxygenase; MVP: measurement of vascular permeability; NF-κB: nuclear factor kappa B; PKC: protein kinase C; PLA2: phospholipase A2; PG: prostaglandin, 5-HT: 5-hydroxytryptamine.